4.8 Review

Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 9, Pages 3022-3032

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI42142

Keywords

-

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Canadian National Institute for the Blind
  3. CIHR training initiative
  4. Heart and Stroke Foundation of Canada (HSCF)
  5. Canadian Stroke Network (CSN)
  6. Charles A. King Trust

Ask authors/readers for more resources

Retinopathy of prematurity (ROP) is a major complication of preterm birth. It encompasses a spectrum of pathologies that affect vision, from mild disease that resolves spontaneously to severe disease that causes retinal detachment and subsequent blindness. The pathologies are characterized by an arrest in normal retinal vascular development associated with microvascular degeneration. The resulting ischemia and retinal hypoxia lead to excessive abnormal compensatory blood vessel growth. However, this neovascularization can lead to fibrous scar formation and culminate in retinal detachment. Present therapeutic modalities to limit the adverse consequences of aberrant neovascularization are invasive and/or tissue-destructive. In this Review, we discuss current concepts on retinal microvascular degeneration, neovascularization, and available treatments, as well as present future perspectives toward more profound elucidation of the pathogenesis of ROP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available